Background and Objectives: Diabetes mellitus is a prevalent chronic disease caused by inadequate insulin secretion or ineffective insulin response, leading to complications such as retinopathy, nephropathy, heart attacks, and strokes. Recently, “diabetes distress (DD)” has emerged as a concept, highlighting the significant emotional burden of managing diabetes, which can impact disease outcomes. Thus, this study evaluates the impact of virtual clinics on diabetes distress and glycemic measures in individuals with diabetes mellitus. Materials and Methods: A cross-sectional study was conducted between May and August 2024 at the Endocrine and Diabetes Center in Alahsa, Saudi Arabia, targeting persons aged 18 and older with diabetes who had engaged in-person clinics, virtual clinics, or both between 2019 and 2024. Data were collected through structured phone interviews, supplemented by laboratory results from clinical records. The survey included demographic details, diabetes information, and the Diabetes Distress Scale. Statistical analyses, including descriptive statistics, were performed to explore the relationships between diabetes distress, clinic visit type, and glycemic control, with Mann–Whitney and Chi-Squared tests used to compare variables between two groups. Results: Of the 108 participants, 55.6% were male, with a mean age of 38.5 years. Type 2 diabetes was reported in 51.9% of individuals, while 48.1% had type 1. High emotional burden (44.4%) and regimen-related distress (28.7%) were prevalent, particularly among individuals with suboptimal glycemic control. While virtual visits were not significantly correlated with lower distress levels, individuals with suboptimal glycemic control exhibited significantly higher diabetes distress across various domains, including emotional and regimen-related distress (p < 0.05). Laboratory analysis showed a median HbA1c of 8.2%, with poor control associated with greater distress. Conclusions: Diabetic individuals with suboptimal glycemic control report higher diabetes distress levels, underscoring the need for integrated psychological support in DM care. Although virtual clinic visits did not significantly reduce distress, they provide a feasible option for individual follow-up.

Comamonas testosteroni is an uncommon environmental Gram-negative bacillus rarely implicated in human infections. We report a case of a 34-year-old male who presented with acute appendicitis complicated by a sealed perforation. Laparoscopic appendectomy was performed, and postoperative cultures identified C. testosteroni in the appendiceal tissue, alongside Pseudomonas aeruginosa and Streptococcus anginosus in the peritoneal fluid. Initial empirical antibiotics were escalated to piperacillin–tazobactam based on culture results. The patient recovered uneventfully and was discharged on postoperative day nine. This case highlights the emerging clinical relevance of C. testosteroni and the importance of microbiological evaluation in guiding management of perforated appendicitis.

Background/Objectives: Diverticular disease (DD) affects a significant portion of the aging population and is increasingly linked to gut microbiota alterations. Probiotics have emerged as a potential adjunct therapy, particularly in managing symptoms and inflammation. The evidence for the recommended use of probiotics in clinical practice for management of diverticular disease is still a matter of controversy. Methods: A comprehensive literature search was conducted across five major databases up to October 2024. Eligible studies included randomized controlled trials (RCTs) and observational studies assessing probiotic use in adult patients with diverticular disease. Results: Thirteen studies met the eligibility criteria. Probiotic therapy was associated with improvement in abdominal pain (SMD 0.63; 95% CI: 0.38–0.88). For bloating, probiotics demonstrated a small trend toward improvement (SMD 0.158; 95% CI: −0.107 to 0.422), although this did not reach statistical significance. C-reactive protein (CRP) outcomes were reported in three studies conducted in acute uncomplicated diverticulitis. All showed reductions in CRP following probiotic therapy; however, substantial variability in baseline levels and assessment timepoints prevented a reliable pooled estimate, and findings were summarized descriptively. Long-term outcomes from two RCTs showed a reduced risk of recurrence (RR 0.22; 95% CI: 0.095–0.510), with multi-strain and longer-duration regimens appearing more beneficial. Conclusions: Probiotics, particularly multi strain formulations administered over longer durations, may help improve symptoms and reduce inflammatory activity in diverticular disease; however, the certainty of evidence remains low to very low due to heterogeneity and methodological limitations. Larger, high-quality randomized trials are needed to clarify the long-term clinical impact of probiotic therapy.